Dr Lynley Marshall completed her undergraduate training in Johannesburg, South Africa, and South West England. She trained in paediatrics and then as a paediatric oncologist in Bristol and Oxford before joining The Royal Marsden.
She now leads the Paediatric and Adolescent Oncology Drug Development Team, focusing on oncology drug development and experimental therapeutics for high risk, poor prognosis malignancies, specifically solid tumours and neuro-oncology.
She is a member of the MCRI Children’s cancer and Leukaemia Clinical Studies Novel Agents Subgroup and the Innovative Therapies for Children with Cancer (ITCC) European Early Phase Trials Consortium.
She has a PhD from the Institute of Cancer Research in the area of novel therapeutics for paediatric high grade glioma.